Format

Send to

Choose Destination
Cancer Cell. 2003 Jul;4(1):7-11.

Getting oncolytic virus therapies off the ground.

Author information

1
Ottawa Regional Cancer Centre, 503 Smyth Road, Ottawa, Ontario K1H 1C4, Canada. john.bell@orcc.on.ca

Abstract

An international meeting was held on the development and application of replicating viruses for cancer therapy this past March in Banff, Alberta. In this review, using the presentations at this meeting as a backdrop, we discuss how recent scientific and clinical findings are reshaping the development of oncolytic virus therapeutics. Here we identify some of the obstacles that these therapeutics face and discuss evolving strategies, both preclinically and clinically, that are facilitating oncolytic virus development.

PMID:
12892708
DOI:
10.1016/s1535-6108(03)00170-3
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center